These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 19949927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1.
    Chang XB.
    Cancer Metastasis Rev; 2007 Mar; 26(1):15-37. PubMed ID: 17295059
    [Abstract] [Full Text] [Related]

  • 3. The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1).
    Sauna ZE, Peng XH, Nandigama K, Tekle S, Ambudkar SV.
    Mol Pharmacol; 2004 Mar; 65(3):675-84. PubMed ID: 14978246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily.
    Altenberg GA.
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):53-62. PubMed ID: 14754412
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of multidrug transporters in drug availability, metabolism and toxicity.
    Bodó A, Bakos E, Szeri F, Váradi A, Sarkadi B.
    Toxicol Lett; 2003 Apr 11; 140-141():133-43. PubMed ID: 12676459
    [Abstract] [Full Text] [Related]

  • 10. Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets.
    Nagengast WB, Oude Munnink TH, Dijkers EC, Hospers GA, Brouwers AH, Schröder CP, Lub-de Hooge M, de Vries EG.
    Methods Mol Biol; 2010 Apr 11; 596():15-31. PubMed ID: 19949918
    [Abstract] [Full Text] [Related]

  • 11. Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis.
    Buyse F, Hou YX, Vigano C, Zhao Q, Ruysschaert JM, Chang XB.
    Biochem J; 2006 Jul 01; 397(1):121-30. PubMed ID: 16551273
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.
    Coley HM.
    Methods Mol Biol; 2010 Jul 01; 596():341-58. PubMed ID: 19949931
    [Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms for tumour resistance to chemotherapy.
    Pan ST, Li ZL, He ZX, Qiu JX, Zhou SF.
    Clin Exp Pharmacol Physiol; 2016 Aug 01; 43(8):723-37. PubMed ID: 27097837
    [Abstract] [Full Text] [Related]

  • 17. Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
    Munoz M, Henderson M, Haber M, Norris M.
    IUBMB Life; 2007 Dec 01; 59(12):752-7. PubMed ID: 18085475
    [Abstract] [Full Text] [Related]

  • 18. Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.
    Jaiswal R, Raymond Grau GE, Bebawy M.
    Future Oncol; 2014 Mar 01; 10(4):655-69. PubMed ID: 24754595
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1.
    Wesołowska O.
    Acta Biochim Pol; 2011 Mar 01; 58(4):433-48. PubMed ID: 22187677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.